Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
1 OF US INC
Financial strength (30%)
76/100
Reliability (20%)
50/100
Effectiveness (25%)
68/100
Impact (25%)
55/100
CharityAI™ Score
Not yet evaluated
Mission Statement
To offer aid and comfort to breast cancer patients and their families facing financial crisis due to the diagnosis of the disease, by providing assistance for their unique non-medical needs that would prevent them from receiving or completing their treatment
Financial Overview — FY 2025
$352K
Total Revenue
$472K
Total Expenses
$367K
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
72.0%
Fundraising Efficiency
90.9%
Operating Reserve
9.34x
Liability-to-Asset
2.4%
Revenue Diversification
99.8%
Executive Compensation
$70K
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
72.0% | 83.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.9% | 10.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.1% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
90.9% | 15.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.3 mo | 11.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.4% | 0.6% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.8% | 93.4% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
8.5% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
13.1% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-34.2% | 4.2% |
P10P90
|
Impact
1 program| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| To have patients healthy and working again. | 500 | $750.00 | — | Per Year |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $352K | $472K | $367K | 72.0% | 2 |
| 2024 | $324K | $417K | $456K | 66.6% | 2 |
| 2023 | $410K | $498K | $549K | 80.2% | 3 |
| 2022 | $291K | $280K | $638K | 69.9% | 3 |
| 2021 | $370K | $250K | N/A | — | 3 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.